Delivery Order SPE2DB24D2003-SPE2DB24FXFH3

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,055.23, is for the delivery of Varenicline 1 mg tablets over a term ending on March 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,586,222 Varenicline 0.5 mg tablets. The firm-fixed-price contract, valued at $1,303.08, has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) awarded a $1,707.60 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 56 tablets of the prescription medication varenicline 1 mg. This delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities, including...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply the U.S. Department of Defense with varenicline 0.5 mg tablets. The contract has a ceiling value of $2,522.62 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a $1,508.67 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565535452 VARENICLINE 1 MG TABLET 56S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract, valued at $1,806.76, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Varenicline 1 mg tablets. The contract has a ceiling value of $1,533.64 and a performance period through September 28, 2023. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under a larger indefinite delivery contract (IDC) with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,163.31 firm fixed-price delivery order is for the supply of 56 tablets of the medication Varenicline 1 mg. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.94 firm fixed-price delivery order is for the supply of 4,567,409,332 tablets of the medication Varenicline 0.5 mg, with a completion date of February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a $2,660.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,178,712 units of the prescription medication varenicline 1 mg tablet, with a completion date of May 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXFH3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract valued at $1,673.82 for the supply of 4,565,031,699 units of the drug varenicline 1 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The current delivery order does not have a set-aside designation, indicating it was awarded on a full and open competition basis. This contract allows the DLA to efficiently procure essential medical commodities to fulfill its mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies.

Generated 9/27/24, 9:32 AM